UNSPSC 51202002: Hyaluronan or hyaluronate or hyaluronic acid

This classification denotes a glycosaminoglycan, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S270N0TRQY. European Medicines Agency schedules Hyaluronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14126MIG. Hyaluronic acid generally arises in the molecular formula C14H23NO12(C14H21NO11)N. The term 'hyaluronic acid' is a Hazardous Substances Data Bank designation. SMILES: CC(=O)NC1C(C(C(OC1O)CO)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)C(=O)O)O)O)O)NC(=O)C)O)O.

UNSPSC 51202002 Hyaluronan or hyaluronate or hyaluronic acid is a Commodity code that the source does not support with activity related to its nominal scope. The single recent state and local opportunity tagged to this code—a July 2026 Mississippi State Department of Health sole source notice for Yellow Fever Vaccine from Sanofi Pasteur, Inc.—is plainly unrelated to hyaluronic acid products. The mismatch indicates either a coding error in the source record or a misalignment between the code taxonomy and the actual procurement being conducted. No other recent opportunities appear in the source.

Without activity grounded in the code's actual scope, no meaningful profile of issuing bodies, geographic concentration, or representative work can be drawn. A business development professional evaluating this code should flag the disconnect and verify the correct UNSPSC classification for hyaluronic acid procurement at the state and local level before committing resources to this code.